The aim of this study was to evaluate office and 24 h blood pressures in women with polycystic ovary syndrome (PCOS) and normal controls in relation to insulin sensitivity. Office blood pressure, insulin sensitivity (euglycaemic hyperinsulinaemic clamp) and body fat distribution (skinfolds, waist:hip ratio) were investigated in 36 women with PCOS and 55 controls [body mass index (BMI) for PCOS patients, mean (confidence interval) 263 (24.6-282); controls, 25.1 (24.0-26.9)], and ambulatory 24 h blood pressure was recorded in representative subgroups of 17 and 16 women respectively. Compared with the controls, the women with PCOS had higher day-time systolic (mean ± SD, 126 ± 11 versus 119 ± 12 mm Hg, P < 0.05) and mean arterial blood pressures (92 ± 7 versus 86 ± 7 mm Hg, P < 0.05) in ambulatory recordings, and greater increases in pulse rate (70%; P < 0.05) from night to day-time recordings, whereas the groups did not differ significantly in day-time diastolic blood pressure (74 ± 6 versus 70 ± 6 mm Hg, P = 0.05) or in night-time recordings. The women with PCOS had a more pronounced truncalabdominal fat distribution (P < 0.05) and a lower insulinmediated glucose disposal (P < 0.01) during the clamp. The increased day-time blood pressures in women with PCOS persisted after adjusting for BMI, body fat distribution and insulin resistance. It is concluded that women with PCOS have an increased prevalence of labile blood pressure, which may indicate a pre-hypertensive state, adding a further risk factor for cardiovascular disease in these women.
Introduction
An association between hypertension and resistance to the action of insulin on carbohydrate metabolism has been found in different study populations (Ferrannini et al., 1987) . Insulin resistance is a common feature of polycystic ovary syndrome (PCOS), observed in the majority of obese and in a varying proportion of non-obese women (Dunaif et al., 1989; Falcone et al., 1992; Anttila et al., 1993; Insler et al., 1993; Holte et al., 1994a,b) . Recently, an increased prevalence of both hypertension and hyperinsulinaemia was found in perimenopausal women with previously biopsy-proven polycystic ovaries compared with controls of similar age and body mass index (BMI) (Dahlgren et al., 1992) . However, in younger women with PCOS, Zimmermann et al. (1992) found similar blood pressures in ambulatory 24 h measurements as in controls, despite insulin resistance in the women with PCOS. Diverging results in pre-menopausal women with PCOS have also been found for the serum lipoprotein profile, another cornerstone of the insulin resistance syndrome (Graf et al., 1990; Conway et al., 1992; Holte et al., 1994b) . Obviously, because PCOS is a highly prevalent endocrine disturbance, it is of gTeat interest to clarify whether these women do run an increased risk of cardiovascular disease, and whether an adverse profile of risk factors, including increased blood pressure, can be detected at a fairly young age.
In our study, 24 h ambulant blood pressure was recorded in women with PCOS of varying BMI and compared with that of women with normal ovaries and regular menstruation. Blood pressure was related to basal endocrine concentrations, anthropometric measures and insulin sensitivity, measured with the hyperinsulinaemic euglycaemic clamp.
Materials and methods
In total, 36 women with PCOS and 55 controls were investigated, with both groups covering a wide range of BMI. The diagnosis of PCOS was based on a disturbed menstrual pattern, indicating ovulatory disturbances and a typical appearance of the ovaries on ultrasound examination (Adams et al., 1986) . Of the women with PCOS, 20 (56%) had oligomenorrhoea and 16 had amenorrhoea (44%). All the ultrasound examinations were performed by one operator (J.H.), either transabdominally or transvaginally (3.5 and 5 MHz sector probe respectively; Acuson 128/10®; Acuson Corporation, Mountain View, CA, USA). Hirsutism was assessed by the protocol used by Ferriman and Gallwey (1961) , with a woman having a score of seven or more points being considered clinically hirsute. Hirsutism was diagnosed In 23 women with PCOS (64%). The control women were volunteers, students or hospital staff, with regular menstruation, no hirsutism and normal ovaries on pelvic ultrasound. Informed consent was obtained from all the women, and the study protocol was approved by the Human Ethics Committee of the Medical Faculty, Uppsala University, Uppsala, Sweden. All the women underwent anthropometric and basal endocrine investigations, including fasting insulin and glucose concentrations, and office blood pressure measurements. Insulin sensitivity was evaluated by the euglycaemic hyperinsulinaemic clamp. The last recruited 17 women with PCOS and 16 controls were assigned to 24 h ambulatory blood pressure monitoring. These subgroups were representative for the entire groups in terms of anthropometric, endocrine and metabolic measures. In the subgroups, mean (95% CI) age was similar in the control and PCOS women [26.4 (24.2-28.6) and 26.3 years (24.3-28.3 ) respectively], whereas the control women in the whole study group were slightly older than the women with .7); P < 0.05]. Therefore, an adjustment for age was performed in all analyses in which age had a significant influence. The women were in good general health and none had been taking hormonal medication or oral contraceptives during the 3 months before the investigation. Plasma concentrations of thyroid hormones, growth hormone and cortisol were normal in all the subjects. 21-Hydroxylase deficiency was excluded in the women with PCOS by serum concentrations of 17-hydroxyprogesterone <5 nmol/1. No woman was suffering from virilism. There were no significant differences in first degree heredity for hypertension (PCOS, 35%; controls, 38%) or in the prevalence of smokers (PCOS, 35%; controls, 25%). As assessed by questionnaires, physical activity at work and leisure time did not differ between the groups, nor did self-estimated basal anxiety or stress levels (Spielberger, 1983) .
Anthropometric measures
The BMI was calculated as weight (kg) divided by height (m) squared. The waist:hip ratio (WHR) was calculated from the circumferences measured in duplicate in the supine position. Skinfolds were measured with a Harpenden skinfold calliper (British Indicator Ltd, Burgess Hill, UK) at the following sites: subscapular, supra-iliac, umbilical and anteriorly and posteriorly at the thigh. The sums of truncalabdominal skinfolds (umbilical, subscapular and supra-iliac) and thigh skinfolds (anterior and posterior) were calculated, as was the ratio between these two sums (trunk:thigh skinfolds ratio).
Metabolic and endocrine investigations
The euglycaemic insulin clamp technique was used to assess insulin sensitivity (Pollare et al., 1990) . The infusion rate of insulin (biosynthetic human insulin Actrapid; Novo Nordisk, Bagsvaerd, Denmark) was 56 mIU/m 2 per min in all the subjects, resulting in a slightly higher mean [95% confidence interval (CI)] plasma insulin concentration (between 60 and 120 min) in women with PCOS compared with controls [113 (104-123) versus 100 (95-106) mIU/1; P < 0.05]. Euglycaemia was maintained by adjusting the rate of infusion of a 20% glucose solution to the plasma glucose measured (Beckman*2; Beckman, Fullerton, CA, USA) every 5 min. The coefficient of variation for the steady-state plasma glucose concentration for a single clamp was 3.7%. The glucose uptake (M) was calculated from the amount of glucose infused during the last 60 min of the clamp, divided by the body weight (kg), and the insulin sensitivity index, Mil, by dividing M by the mean steady-state insulin concentration (/) during the same time period (mg/kg body weight/min/mlU/lX 100).
Assessment of free fatty acids (FFA)
Plasma FFA concentrations were determined using enzymatic methods (Wako Chemicals Gmbh, Neuss, Germany) applied for analyses in a Multistat HI F/LS (Instrumentation Laboratories, Lexington, MA, USA). The coefficient of variation, compared with a standard, for the determination of the FFA concentration was 9.1 %.
Blood for the honnone measurements was obtained before the start of the metabolic studies, between 07:30 and 08:00 h, during rest in the supine position and after one night's fasting. AH endocrine and metabolic investigations were performed during the early follicular phase in women with regular menstruation or oligomenorrhoea, and within 1 week of each other in women with amenorrhoea. Serum concentrations of gonadotrophins were analysed on both occasions, and the mean values were used for calculations. Follicle stimulating hormone (FSH) and luteinizing hormone (LH) were measured with non-competitive sandwich fluoroimmunoassays (Delfia hFSH and Delfia LH Spec; Wallac Oy, Turku, Finland). Immunoreactive insulin was assayed in plasma by radioimmunoassay (Phadeseph'", insulin radioimmunoassay; Pharmacia, Uppsala, Sweden). The values for FSH and LH were expressed in IU/1 using the Second International Reference Preparation (IRP) of pituitary FSH/LH (ICSH), human, for bioassay (78/549) and the Second International Standard (IS) for pituitary LH for immunoassay (80/552) respectively. Oestradiol, testosterone, dehydroepiandrosterone sulphate (DHEA-S) and androstenedione concentrations were measured using competitive radioimmunoassays (Coat-A-Count oestradiol, Coat-A-Count total testosterone and Coat-A-Count DHEA-SO 4 from Diagnostic Products Corporation, Los Angeles, CA, USA; androstenedione radioimmunoassay kit from Amersham International, Amersham, UK). Concentrations of sex hormone-binding globulin (SHBG) in serum were analysed using a dihydrotestosterone saturating method (Rosner, 1972) . The free androgen index (FAI) was calculated from (testosterone/SHBG)X100. The within-and befween-assay coefficients of variation were 2.5 and 3.6% for FSH, 2.6 and 3.5% for LH, 7.3 and 8.2% for growth honnone, 1.6 and 3.7% for prolactin, 5.5 and 7.0% for oestradiol, 5.0 and 8.0% for testosterone, 5.5 and 10.0% for DHEA-S, 3.0 and 7.0% for androstenedione, 7.0 and 10.0%, for SHBG and 4.7 and 6.2% for insulin.
Office and ambulatory blood pressure recordings
The woman was placed at rest in the supine position for 10 min before the recording was taken. A mercury sphygmomanometer (Kifa Ercameter, width 12.5 cm, length 35.0 cm) was used; for obese women (arm width S=32 cm), a larger cuff was used. The systolic blood pressure was defined as Korotkov phase 1 and the diastolic pressure as phase V. The mean of three measurements was used for the analyses. Ambulatory blood pressure monitoring was performed using the Accutracker II device (Suntech Medical Instruments, Inc., Raleigh, NC, USA), which uses the auscultatory method. Each patient was attached to the device for 24 h during a normal work day. The patients were instructed to refrain from consuming alcohol, to keep a low consumption of coffee, tea and cigarettes, and to avoid vigorous arm movements during blood pressure measurements. The cuff was attached to the patient's left arm and chest, and ECG electrodes were affixed by a skilled technician. Systolic and diastolic blood pressures were measured every 30 min between 06:00 and 23:00 h, and every 60 min between 23:00 and 06:00 h. The data were edited to a limited extent, deleting all readings of 0, all heart-rate readings <30 beats per minute (b.p.m.), diastolic blood pressure readings >170 mm Hg, systolic blood pressure readings >270 and <80 mm Hg, and readings where the difference between the systolic and diastolic blood pressures was <10 mm Hg.
Statistics
Student's two-tailed /-test was used for comparisons of means of variables, which were normally distributed either before or after log transformation, and Wilcoxon's rank test was employed for variables not normally distributed after log transformation. Pearson's correlation coefficients were used for simple linear correlations. To separate the impact of PCOS and BMI on some variables, BMI was added as a covariate to the analysis. All statistical analyses were performed withi the statistical program packages Statistical Analysis System and JMP (SAS Institute Inc., NC, USA).
Results

Basal anthropometric, endocrine and metabolic investigations
The women with PCOS had a more pronounced truncalabdominal adiposity according to skinfold measurements, i.e. Values are geometric or "arithmetic means (95% confidence intervals). Student's r-test was used for group comparisons. Table IV . Blood pressure and heart rate in women with polycystic ovarian syndrome (PCOS; n = 18; except for office measurements, n = 36) and control subjects (n = 17; except for office measurements, n = 55) a higher sum of truncal-abdominal skinfolds and its ratio to compared with controls (Table H) . The ovarian volume was the sum of thigh skinfolds; as well as a higher WHR than the controls (Table I) . Serum concentrations of FSH and SHBG were lower in women with PCOS (Table U) , and those of LH, androstenedione, testosterone and DHEA-S, and hence the LH:FSH ratio and the FAI, higher in women with PCOS larger in the women with PCOS than in controls (Table H) . Serum concentrations of fasting insulin were higher in the PCOS group, the glucose disposal (M) and the insulin sensitivity index {Mil) during the insulin clamp were lower in the PCOS group, and fasting plasma glucose concentrations were
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Time (hour) (Table HI) . According to an analysis of covariance, BMI and PCOS had synergistic effects on insulin resistance (P < 0.05), resulting in similar Mil values at BMI 20 kg/m 2 , whereas the controls had a 55% higher mean Mil value at a BMI of 30 kg/m 2 . Similarly, fasting insulin concentrations were 10 and 70% higher in the PCOS group at BMI values of 20 and 30 kg/m 2 respectively (P < 0.05). Plasma concentrations of FFA did not differ between the groups as a whole (Table HI) , but the BMI had a more pronounced effect on FFA in the PCOS group (P < 0.05), resulting in 28% higher concentrations at a BMI of 30 kg/m 2 , despite similar concentrations at a BMI of 23 kg/m 2 .
Office and ambulatory 24 h blood pressure
No woman, in either group, had hypertension according to World Health Organization criteria. Office recordings showed no significant differences in systolic or diastolic blood pressures (P = 0.17 and P = 0.07 respectively after age correction; Table IV ). The BMI had a similarly positive influence on office blood pressure in both groups {P < 0.001 and P < 0.05 for systolic and diastolic pressures respectively). The 24 h ambulatory recordings (Figure 1 ) showed higher systolic (P < 0.05) and mean arterial blood pressures (P < 0.05) during the day time in the women with PCOS than in controls, whereas the groups did not differ in the diastolic day-time blood pressure (P = 0.05) or in the blood pressure during the night (systolic P-0.8; diastolic P = 0.4; mean arterial P = 0.5; Table IV ). The differences in day-time recordings persisted after adjusting for heredity for hypertension, smoking history, BMI, body fat distribution and insulin resistance. The 24 h heart rate was similar in both groups, and was correlated with fasting insulin (r = 0.45; P < 0.01) and inversely with the M value (r = 0.47; P < 0.01) in the entire population, independent of the BMI and body fat distribution. The increase in heart rate from night to day time recordings was 70% higher [15.5 (11.2-19.9) versus 9.1 b.p.m. (4.6-13.5); P < 0.05], and the corresponding increase in systolic blood pressure was 55% [14.9 (9.3-20.5) versus 9.6 (4.5-14.7) mm Hg; P = 0.06] higher in the PCOS group compared with the control group. Age was significantly correlated with office systolic ( r = 0.44; P < 0.01) and diastolic (r = 0.47; P < 0.01) blood pressures and 24 h systolic (r = 0.49; P < 0.05) and diastolic blood pressures (r = 0.64; P < 0.01), independent of BMI, in the PCOS group, but not in the controls. In the PCOS group, the office systolic blood pressure was significantly correlated with fasting insulin (r = 0.53; P < 0.01), M/I (r = 0.50; P < 0.01), FFA (r = 0.52; P < 0.01) and FAI (r = 0.48; P < 0.01), all independent of age, BMI and body fat distribution.
Discussion
This study shows that ambulatory day-time systolic and mean arterial blood pressures were higher in women with PCOS compared with women with normal ovaries and regular menstruation. Previous studies have shown either similar (Conway et al., 1992) or increased (Rebuffe-Scrive et al., 1989) office blood pressures in lean women with PCOS in comparison with lean controls, whereas the interpretation of the elevated blood pressures reported in obese women with PCOS is complicated by a lack of weight-matched controls (Mattsson et ai, 1984; Conway et ai, 1992) . In the only previous study in which 24 h ambulatory blood pressures were recorded in women with PCOS, Zimmermann et al. (1992) could not find differences in the mean blood pressure despite a lower insulin sensitivity in the PCOS group than in the controls. The differences in blood pressure in our study were moderate, given the profound insulin resistance found in the obese women; in that respect our data are analogous to those of Zimmermann et aL (1992) . Furthermore, the distribution of blood pressure was skewed, indicating that a subpopulation of women with PCOS was responsible for the overall slightly increased day-time blood pressure in that group. Thus, heterogeneity in blood pressure in the PCOS group may greatly affect the results in such medium-sized data sets as ours and that of Zimmermann et al. (1992) .
A key question is whether a modest rise in day-time blood pressure, as observed in the women with PCOS, predates hypertension. To date, there are no long-term follow-up data to answer this question. However, 24 h ambulatory measurements are considered to provide more reliable prognostic information and to be a more accurate method than office measurements for revealing labile blood pressure or borderline hypertension (de Faire et al., 1993) . Whether this is also the case for isolated increases in day-time blood pressure is not clear at present A recent study has shown that, at the age of 50 years, a high proportion of women diagnosed earlier with biopsy-verified PCOS will have manifest hypertension (Dahlgren et al., 1992) . The strong association between age and both systolic and diastolic blood pressure in the PCOS group, a relationship which was absent among the controls, may further suggest such an ongoing development in the women with PCOS. In addition, there were signs of sympathetic over-activity in the PCOS group (a more pronounced increase in heart rate during the day), which could indicate a prehypertensive constitution (Julius et al., 1992) .
Insulin resistance is a prevalent feature of subjects with essential hypertension (Ferrannini et al., 1987 (Ferrannini et al., , 1990 Zavaroni et al., 1989) , and in a longitudinal study in men, hyperinsulinaemia predicted the later development of hypertension (Skarfors et al., 1989 ). An inverse association between insulin sensitivity and systolic blood pressure was found in the PCOS group in office measurements. Elevated blood pressure was not confined entirely to the obese insulin-resistant women, and a close association with truncal-abdominal fat mass, as observed for insulin resistance (Holte et al., 1994a (Holte et al., ,b, 1995 , was not seen for blood pressure. However, despite normal insulin sensitivity, slight hyperinsulinaemia was also found in the lean women with PCOS, analogous to our previous findings of an exaggerated insulin secretion in lean women with PCOS, not dependent on insulin resistance (Holte et al., 1994a) . Consequently, the signs of elevated blood pressure found in both lean and obese women with PCOS were paralleled by elevated plasma insulin concentrations, but only in the obese women by a decreased insulin action on glucose disposal.
There are several putative mechanisms that could account for this association in women with PCOS. Hyperinsulinaemia is often associated with an increased sympatho-adrenal tone, which could be caused by a common neuro-endocrine aberration, or through cause and effect relationships in either direction (Ferrannini et al, 1987; Berne et al., 1992; Julius et al., 1992) . The close correlations between plasma FFA and systolic blood pressure, the greater elevations in heart rate from night-to day-time recordings in the women with PCOS than in controls, and previous reports of increased epinephrine concentrations (Zimmermann et al., 1992) and an enhanced catecholamine turnover in PCOS (Lobo et al., 1983) women support the involvement of an increased activity of the sympatho-adrenal system in the blood pressure elevations in the women with PCOS.
A further possible contributing mechanism is hyperreactivity in the hypothalamic-pituitary-adrenal axis, which may be a common candidate responsible for truncal-abdominal obesity, insulin resistance and hypertension. Recent findings in women with upper body obesity and in those with a diagnosis of PCOS suggest that there may indeed be a generalized increased adrenal activity with a functional hypercortisolism (Marin et al., 1992; Pasquali et al., 1993; Whitworth, 1994) .
Finally, the associations between the index of active testosterone (FAI) and systolic blood pressure, corroborating previous findings in women (Wu et al., 1990) , may indicate a pathogenic effect of androgens, as has been shown in studies on spontaneously hypertensive rats (Chen and Meng, 1991) . The muscular effects of testosterone may indirectly induce both insulin resistance and hypertension (Holmang et al., 1990) .
In summary, women with PCOS exhibited slightly higher systolic and mean arterial blood pressures during the day time in 24 h recordings compared with controls of similar BMI. Although the blood pressure elevations were heterogeneous and modest, especially considering the profound insulin resistance in the obese women, the greater increase in pulse rate from night-to day-time recordings and the strong correlation between blood pressure and age in the PCOS group may indicate an increased prevalence of a labile, pre-hypertensive state in these young women.
